Publication | Closed Access

Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study

VaccinationVaccine SafetyVaccine DevelopmentLatin American InfantsPediatricsRotavirus GastroenteritisVirologyGastrointestinal VirusMedicineVaccine ResearchHuman Rotavirus Vaccine